Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant
Reading Time: < 1 minute
Author: Suthira Taychakhoonavudh
Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: Protective efficacy, immunogenicity, safety, and toxicity
Reading Time: < 1 minute
Situation of snakebite, antivenom market and access to antivenoms in ASEAN countries
Reading Time: < 1 minute
Plant-produced recombinant SARS-CoV-2 receptor-binding domain; an economical, scalable biomaterial source for COVID-19 diagnosis
Reading Time: < 1 minute
Molecular Pharming for low and middle income countries
Reading Time: < 1 minute